Key Insights

Highlights

Success Rate

89% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

10.0%

1 terminated out of 10 trials

Success Rate

88.9%

+2.4% vs benchmark

Late-Stage Pipeline

10%

1 trials in Phase 3/4

Results Transparency

0%

0 of 8 completed with results

Key Signals

89% success

Data Visualizations

Phase Distribution

8Total
Not Applicable (7)
P 4 (1)

Trial Status

Completed8
Terminated1
Unknown1

Trial Success Rate

88.9%

Benchmark: 86.5%

Based on 8 completed trials

Clinical Trials (10)

Research Network

Activity Timeline